Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
MiNK TherapeuticsINKT | Open-market sale | 06/04 | 06/05 | 1,500 sh2 trades | $12.76avg. | $19,140 | −6.4% | |
MiNK TherapeuticsINKT | Open-market sale | 03/09–03/10 | 03/11 | 1,500 sh4 trades | $14.70avg. | $22,053 | −6.8% | |
MiNK TherapeuticsINKT | Open-market sale | 02/27–03/02 | 03/04 | 500 sh2 trades | $10.85avg. | $5,427 | −2.2% | |
10% Owner | MiNK TherapeuticsINKT | Open-market buy | 23/10/12–23/10/16 | 23/10/16 | 22,975 sh3 trades | $1.10avg. | $25,272.5 | +0.1% |
Agenus10% Owner | MiNK TherapeuticsINKT | Open-market buy | 23/10/04 | 23/10/06 | 15,001 sh | $1.09 | $16,351.09 | +0.1% |
Agenus10% Owner | MiNK TherapeuticsINKT | Open-market buy | 23/08/29 | 23/08/31 | 29,678 sh | $1.52 | $45,110.56 | +0.1% |
10% Owner | MiNK TherapeuticsINKT | Open-market buy | 23/08/24–23/08/28 | 23/08/28 | 183,052 sh2 trades | $1.53avg. | $280,747.36 | +0.9% |
10% Owner | MiNK TherapeuticsINKT | Open-market buy | 23/05/10–23/05/11 | 23/05/12 | 45,426 sh2 trades | $1.47avg. | $66,724.38 | +0.2% |
Garo H. ArmenDirector | MiNK TherapeuticsINKT | Open-market sale | 23/05/05 | 23/05/05 | 100,000 sh | $0.95 | $95,000 | −5.1% |
10% Owner | MiNK TherapeuticsINKT | Open-market buy | 23/05/03–23/05/05 | 23/05/05 | 250,362 sh4 trades | $1.04avg. | $260,431.18 | +1.2% |
Garo H. ArmenDirector | MiNK TherapeuticsINKT | Open-market buy | 23/05/02 | 23/05/04 | 100,000 sh | $0.95 | $95,000 | +5.3% |
